ENFLONSIA
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ENFLONSIA, covering 2025-06-09 to 2026-06-04. Get the full timeline:
Most recent: EMA Authorised: Enflonsia (clesrovimab) — Merck Sharp Dohme Limited